Molecular Partners Ag (MOLN) Total Non-Current Liabilities (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Total Non-Current Liabilities for 7 consecutive years, with $9.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Non-Current Liabilities rose 63.7% year-over-year to $9.3 million in Q2 2026; TTM through Jun 2026 was $9.3 million, a 63.7% increase from a year earlier, with the FY2025 full-year figure at $13.0 million, up 86.74% from the prior year.
• Total Non-Current Liabilities was $9.3 million for Q2 2026 at Molecular Partners Ag, down from $13.3 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $18.3 million in Q1 2022 and troughed at $4.1 million in Q2 2024.
• A 5-year average of $8.8 million and a median of $8.4 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities sank 58.72% in 2023 and soared 203.34% in 2026, its largest moves.
• Over 5 years, Total Non-Current Liabilities stood at $10.2 million in 2022, then fell by 17.15% to $8.5 million in 2023, then declined by 17.64% to $7.0 million in 2024, then soared by 92.9% to $13.4 million in 2025, then sank by 30.98% to $9.3 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $9.3 million (Q2 2026), $13.3 million (Q1 2026), and $13.4 million (Q4 2025), per Business Quant data.